SMN-C3

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSMN-C3
Drug Alias NameSMN-C3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSurvival motor neuron protein modulators
TargetsSurvival motor neuron protein
Therapy Area/IndicationsMuscular Atrophy, Spinal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics IncF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics IncF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsMuscular Atrophy, Spinal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A